Skip to main content
Egyptian Journal of Medical Human Genetics

Table 2 Structural modification of compound 39 and predicted pGI50 with leverage limit

From: Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line

ID

R1

R2

Predicted pGI50

Leverage-limit

N1

H

Br

9.836

0.329

N2

H

Cl

12.876

0.323

N3

H

NO2

10.901

0.412

N4

H

OMe

11.263

0.218

Back to article page